Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharmaceutical Executive, February 2022 Issue (PDF)
Articles in this issue
As Change Continues, Are You Digitally Fit For the Future?
Ready for Pharma’s Next Chapter
The Tech Perspective: Coordinating a Plan of Engagement
The Importance of Culturally Inclusive and Relevant Marketing
Messaging Makeover
Ethics of Antibiotics
What’s Up in Biotech These Days? Not Much, Unfortunately
Planning for Second to Market in Orphan Disease Space
AI and Analytics Appear Ready to Surge in Sales and Marketing
It’s Time for Companies To See Employees as Full-Time People
EU Steps in on Pricing, Offers Member States Aid to Negotiate
Moving Forward With Pharma
Pharmaceutical Executive, February 2022 Issue (PDF)
Global Vaccine Access Challenges FDA, Industry
Recent Videos
Related Content
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Podcast
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
